VBI Vaccines Alpha and Beta Analysis

This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as VBI Vaccines. It also helps investors analyze the systematic and unsystematic risks associated with investing in VBI Vaccines over a specified time horizon. Remember, high VBI Vaccines' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to VBI Vaccines' market risk premium analysis include:
Beta
(2.85)
Alpha
(1.77)
Risk
0.0
Sharpe Ratio
0.0
Expected Return
0.0
Please note that although VBI Vaccines alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, VBI Vaccines did 1.77  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of VBI Vaccines stock's relative risk over its benchmark. VBI Vaccines has a beta of 2.85  . As returns on the market increase, returns on owning VBI Vaccines are expected to decrease by larger amounts. On the other hand, during market turmoil, VBI Vaccines is expected to outperform it. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

VBI Vaccines Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. VBI Vaccines market risk premium is the additional return an investor will receive from holding VBI Vaccines long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in VBI Vaccines. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate VBI Vaccines' performance over market.
α-1.77   β-2.85

VBI Vaccines Fundamentals Vs Peers

Comparing VBI Vaccines' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze VBI Vaccines' direct or indirect competition across all of the common fundamentals between VBI Vaccines and the related equities. This way, we can detect undervalued stocks with similar characteristics as VBI Vaccines or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of VBI Vaccines' fundamental indicators could also be used in its relative valuation, which is a method of valuing VBI Vaccines by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare VBI Vaccines to competition
FundamentalsVBI VaccinesPeer Average
Return On Equity-4.2-0.31
Return On Asset-0.29-0.14
Operating Margin(9.68) %(5.51) %
Current Valuation38.92 M16.62 B
Shares Outstanding28.68 M571.82 M
Shares Owned By Insiders6.76 %10.09 %
Shares Owned By Institutions13.00 %39.21 %

VBI Vaccines Opportunities

VBI Vaccines Return and Market Media

The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
VBI Vaccines GAAP EPS of -0.73 misses by 0.20, revenue of 1.21M misses by 1.64M
05/15/2024
2
VBI Vaccines slides on discounted stock and warrants offering - MSN
05/17/2024
3
VBI-1901 shows promise in glioblastoma interim study
05/29/2024
4
VBI Vaccines Receives New Coverage from Analysts at StockNews.com - Defense World
06/20/2024
5
Acquisition by Diaz-mitoma Francisco of 40000 shares of VBI Vaccines at 0.5 subject to Rule 16b-3
07/10/2024
6
VBI Vaccines Initiates Restructuring Proceedings Under CCAA to Implement a Review of its Strategic Alternatives
07/30/2024
7
Dow Tumbles 950 Points ISM Services PMI Surges In July
08/05/2024
8
Todays Biggest Pre-Market Stock Movers 10 Top Gainers and Losers onWednesday
08/07/2024

About VBI Vaccines Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including VBI or other delisted stocks. Alpha measures the amount that position in VBI Vaccines has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

VBI Vaccines Upcoming Company Events

As portrayed in its financial statements, the presentation of VBI Vaccines' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, VBI Vaccines' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of VBI Vaccines' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of VBI Vaccines. Please utilize our Beneish M Score to check the likelihood of VBI Vaccines' management manipulating its earnings.
11th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
11th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with VBI Vaccines

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Consideration for investing in VBI Stock

If you are still planning to invest in VBI Vaccines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VBI Vaccines' history and understand the potential risks before investing.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Valuation
Check real value of public entities based on technical and fundamental data